Accuray Operating Expenses 2010-2024 | ARAY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Accuray operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Accuray operating expenses from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$236.9B
Intuitive Surgical (ISRG)	$174.1B
Alcon (ALC)	$48.5B
IQVIA Holdings (IQV)	$44.6B
IDEXX Laboratories (IDXX)	$42.6B
Edwards Lifesciences (EW)	$40.5B
DexCom (DXCM)	$28.8B
STERIS (STE)	$23.6B
SONOVA HOLDING (SONVY)	$21B
Waters (WAT)	$20.1B
Hologic (HOLX)	$19.1B
Sysmex ADR (SSMXY)	$12.5B
Fresenius Medical Care AG KGaA (FMS)	$12.2B
Teleflex (TFX)	$11.6B
Globus Medical (GMED)	$9.6B
Penumbra (PEN)	$7.8B
Glaukos (GKOS)	$7.1B
Masimo (MASI)	$5.9B
TransMedics (TMDX)	$5.5B
Integer Holdings (ITGR)	$4.4B
PROCEPT BioRobotics (PRCT)	$4.3B
Tandem Diabetes Care (TNDM)	$2.9B
LivaNova (LIVN)	$2.8B
Veracyte (VCYT)	$2.7B
Inari Medical (NARI)	$2.6B
Elekta AB (EKTAY)	$2.5B
Nihon Kohden (NHNKY)	$2.3B
RxSight (RXST)	$2B
Integra LifeSciences Holdings (IART)	$1.4B
Pulse Biosciences (PLSE)	$1.1B